There are several possible explanations: Individual Sensitivity: Each persons body reacts differently to medications
At Week 26, the primary HbA1c endpoint was missing for 5.6%, 4.2% and 2.5% of patients randomized to placebo, liraglutide 1.8 mg and semaglutide tablets 14 mg, respectively
Compounded versus brand-name semaglutide: does onset differ
Results from on-going EMPA-KIDNEY (NCT03594110), DELIVER (NCT0319213), SMARTEST (NCT03982381), as well as the recently terminated SCORED (NCT03315143) and SOLOIST-WHF (NCT03521934) trials will further elucidate the cardioprotective effects and identify patients who may benefit most from treatment with SGLT2 inhibitors
These numbers are different levels of discharge capability
Oily/Acne-Prone Skin: Glutathione can help reduce pigmentation